ATLANTA, GA – – (Newsfile Corp. – March 31, 2022) – – Holzer & Holzer, LLC is investigating whether NeoGenomics, Inc. (“NeoGenomics” or the “Company”) (NASDAQ: NEO) complied with federal securities laws.  On March 28, 2022, the Company announced that its CEO was stepping down and further disclosed that it expects “revenue for Q1 2022 may be below the low end of its prior guidance of $118 – $120 million and EBITDA for Q1 2022 will be below the low end of its prior guidance of $(15) – $(12) million.”  Following this announcement, the Company’s stock price dropped. If you purchased NeoGenomics stock and suffered a loss on that investment, you are encouraged to contact Corey D. Holzer, Esq. at  or Joshua Karr, Esq. at, call our toll-free number at (888) 508-6832, or visit our website at to discuss your legal rights.

Provide Your Information To Take Action

  • Date PurchasedNumber of Shares AcquiredAcquisition Price Per Share 
  • Date SoldNumber of Shares SoldSelling Price Per Share 
  • Signed pursuant to the Uniform Electronic Transactions act as adopted by the various states and territories of the United States.

Contact Us

We're not around right now. But you can send us an email and we'll get back to you, asap.

Not readable? Change text. captcha txt